SIFR Trademark

Trademark Overview

On Thursday, September 23, 2021, a trademark application was filed for SIFR with the United States Patent and Trademark Office. The USPTO has given the SIFR trademark a serial number of 79328133. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 18, 2025. This trademark is owned by Cryptobiotix. The SIFR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting preclinical and clinical studies, trials and tests, namely, conducting preclinical and clinical trials for food components and pharmaceutical products
sifr

General Information

Serial Number79328133
Word MarkSIFR
Filing DateThursday, September 23, 2021
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements

Goods and ServicesConducting preclinical and clinical studies, trials and tests, namely, conducting preclinical and clinical trials for food components and pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCryptobiotix
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameCryptobiotix
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Thursday, December 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 6, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 14, 2021APPLICATION FILING RECEIPT MAILED
Saturday, June 25, 2022ASSIGNED TO EXAMINER
Tuesday, July 5, 2022NON-FINAL ACTION WRITTEN
Monday, August 1, 2022REFUSAL PROCESSED BY MPU
Monday, August 1, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 23, 2022REFUSAL PROCESSED BY IB
Tuesday, January 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 9, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, April 12, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 9, 2023SUSPENSION LETTER WRITTEN
Thursday, March 9, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 11, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, November 23, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, February 25, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

sifr trials conducting clinical preclinical pharmaceutical products components tests studies namely